Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

Apitope International N.V.. (10/31/17). "Press Release: Apitope Announces Its Intention to Launch an Initial Public Offering and Listing on Euronext Brussels [Not for release in US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]

Organisations Organisation Apitope International N.V.
  Group Apitope (Group)
  Organisation 2 Euronext Brussels
  Group Euronext (Group)
Products Product ATX-MS-1467 (Apitope)
  Product 2 investment banking
Index term Index term Apitope–SEVERAL: investment, 201710– IPO at Euronext Brussels incl public offering in BE + private placement to qualified investors outside US
Persons Person Martin, Keith (Apitope 200801 CEO)
  Person 2 Clark, Mary (Optimum Strategic Communications 201710 before Hume Brophy + M:Communications + Capital MSL)

Record changed: 2017-11-17


Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for Apitope (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px

» top